Search clinical trials for: empagliflozin medium dose

Total 17120 results

Hospices Civils de Lyon

Recruiting

Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients (DAPA-GUT)

Chronic Kidney Diseases

France
University of Campinas, Brazil
AstraZeneca

Completed

Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery (ADDENDA)

Coronary Artery Disease | Diabetes Mellitus, Type 2 | Carotid Artery Diseases

Brazil
AstraZeneca
Bristol-Myers Squibb

Completed

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Type 2 Diabetes

Sweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
SINA Health Education and Welfare Trust
Horizon Pharmaceutical Pvt Ltd

Completed

Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | Empagliflozin

Pakistan
University Hospital, Basel, Switzerland

Active, not recruiting

Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes (Hypo-PrEA)

Postprandial Hypoglycemia

Switzerland
Colorado Prevention Center
Bayer; Saint Luke's Hospital of Kansas City

Not yet recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) (CONFIRMATION)

Heart Failure
National Institute of Diabetes and Digestive and...

Withdrawn

Empaglifozin in Early Diabetic Kidney Disease

Diabetic Kidney Disease | Diabetes Mellitus Type 2

United States
Cliniques universitaires Saint-Luc- Université...

Unknown

Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency (GLYCO-1B)

Glucose 6 Phosphatase Deficiency | Glycogen Storage Disease Type I

Belgium
University Hospital, Basel, Switzerland

Completed

Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study (SAND)

SIADH

Switzerland
Chinese PLA General Hospital

Unknown

Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI

Reperfusion Injury, Myocardial
Washington University School of Medicine
Juvenile Diabetes Research Foundation

Recruiting

Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency

Diabetes Mellitus, Type 1

United States
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of
AstraZeneca
Biocard

Completed

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

Diabetes Mellitus, Type 2

Russian Federation
University Hospital Tuebingen
AstraZeneca; German Federal Ministry of Education and Research; German Center...

Recruiting

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

Renal Failure | PreDiabetes | Type2diabetes

Germany
Sheba Medical Center

Unknown

Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease

Coronary Disease With Diabetes Mellitus

Israel
University of Texas Southwestern Medical Center

Recruiting

Polypill for Prevention of Cardiomyopathy (PolyPreventHF)

Type 2 Diabetes | High Blood Pressure

United States
The Cleveland Clinic

Completed

Chest Imaging, Breath, and Biomarkers in a Screening Trial

Lung Cancer

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
Boehringer Ingelheim

Completed

Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints

Menopause
GangaGen, Inc.

Completed

Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients

Bacterial Infections | Infectious Disease

Singapore
Getz Pharma

Recruiting

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study (EASE)

Type II Diabetes Mellitus | Safety Issues | Efficacy, Self

Pakistan, Sri Lanka
Boehringer Ingelheim
Eli Lilly and Company; Medical Research Council Population Health Research...

Active, not recruiting

EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

Chronic Kidney Disease

United States, Canada, United Kingdom, China, Germany, Italy, Japan, Malaysia
Medanta, The Medicity, India

Completed

Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes (E-LIFT)

Non Alcoholic Fatty Liver Disease

India
Oslo University Hospital

Completed

Empagliflozin in Renal Transplant Recipients (EMPA-RenalTx)

Diabetes Mellitus | Renal Insufficiency | Safety Issues

Norway
Boehringer Ingelheim

Completed

Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions

Healthy

Russian Federation
Boehringer Ingelheim

Completed

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

China
Taipei Medical University WanFang Hospital

Unknown

Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea

Type 2 Diabetes

Taiwan
Rigshospitalet, Denmark

Recruiting

EMPagliflozin After Aortic Valve Replacement (EMPAVR)

Aortic Valve Stenosis

Denmark
VA Office of Research and Development
VA Pittsburgh Healthcare System; Nashville VA Medical Center; Iowa City VA Health...

Recruiting

Empagliflozin Treatment in Kidney Transplant Recipients (SEKTR)

Type 2 Diabetes | Kidney Transplant

United States
NYU Langone Health
American Society of Clinical Psychopharmacology

Recruiting

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Columbia University

Completed

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

Transthyretin Amyloid Cardiomyopathy

United States
Johannes Gutenberg University Mainz
Boehringer Ingelheim

Completed

Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics (EmDia)

Diabetes Mellitus, Type 2 | Diastolic Dysfunction

Germany
Unity Health Toronto
Boehringer Ingelheim

Unknown

Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes (EMPA-HEART)

Cardiovascular Disease | Diabetes

Canada
Swedish University of Agricultural Sciences
Uppsala University

Completed

The Effect of Dietary Fibre and Plant Protein on Appetite and Metabolic Function

Appetite Regulation

Sweden
Boehringer Ingelheim

Completed

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

Healthy
University of Pisa

Unknown

Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy (PURITY)

Glucose Metabolism Disorders | Renal Function Disorder

Italy
Chiesi Farmaceutici S.p.A.
SGS S.A.

Completed

Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD

COPD

United Kingdom
Menarini Group

Completed

Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride (DAVID-art)

Acute Pain

Serbia, Latvia, Spain, Hungary, Lithuania, Poland, Taiwan, Czech Republic, Germany, Ukraine
Nidae Alaa

Recruiting

Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Diabetic Retinopathy

Egypt
Guangzhou JOYO Pharma Co., Ltd
Chengdu JOYO pharma Co., Ltd.

Not yet recruiting

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis
Beijing Anzhen Hospital

Not yet recruiting

Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation (DARE-AF)

Atrial Fibrillation

China
University Hospitals Cleveland Medical Center
Emory University

Completed

Vitamin D Supplementation in HIV Youth

HIV Infections

United States
Centre Hospitalier Universitaire de Saint Etienne
Sanofi Pasteur, a Sanofi Company; Bioster, a.s.

Completed

Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19 (COVIMMUNAGE)

Covid19

France
University Health Network, Toronto

Recruiting

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK)

Kidney Transplant Recipients

Canada
Hilda Elizabeth Macías Cervantes

Completed

Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography

Myocardial Infarction | Diabetes Mellitus, Type 2 | Unstable Angina | Diabete Type 2

Mexico
Shanghai Zhongshan Hospital

Active, not recruiting

Remission of Type 2 Diabetes With Dapagliflozin (READ Trial) (READ)

Type 2 Diabetes

China
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Type 2 Diabetes

Korea, Republic of
Alexandria University

Recruiting

Cognitive Protective Effect of Newer Antidiabetic Drugs

Type 2 Diabetes

Egypt
Vaxart

Active, not recruiting

A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Norovirus Infections

United States

3

Subscribe